13752-84-6
Chemical Structure
Erythronic acid
- CAS No.: 13752-84-6
- Formula:C4H8O5
- Molecular Weight:136.10
IUPAC Name: (2R,3R)-2,3,4-trihydroxybutanoic acid
InChIKey: JPIJQSOTBSSVTP-PWNYCUMCSA-N
SMILES: O=C(O)[C@H](O)[C@H](O)CO
Biological Activity: Erythronic acid is a urinary metabolite that serves as a diagnostic marker for transaldolase (TALDO) deficiency. Erythronic acid is a differential urinary metabolite associated with renal injury in hyperuricemic rats. Erythronic acid can be used in studies related to transaldolase deficiency and hyperuricemia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Erythronic acid | Erythronic acid is a urinary metabolite that serves as a diagnostic marker for transaldolase (TALDO) deficiency. Erythronic acid is a differential urinary metabolite associated with renal injury in hyperuricemic rats. Erythronic acid can be used in studies related to transaldolase deficiency and hyperuricemia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Engelke UF, et al. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency. Biochimica et biophysica acta. 2010 Nov;1802(11):1028-35.
- [2]. Halimulati M, et al. Anti-Hyperuricemic Effect of Anserine Based on the Gut-Kidney Axis: Integrated Analysis of Metagenomics and Metabolomics. Nutrients. 2023 Feb 15;15(4):969.